QIAGEN announces broadening of GeneReader NGS System applications into hereditary disease analysis | Business Wire

By July 3, 2018News

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today introduced seamless next-generation sequencing (NGS) solutions for a wide range of hereditary diseases on the GeneReader NGS System, the complete Sample to Insight NGS solution for any lab worldwide.

View Original Article »

Join our Mailing List